SLI
2.016,48
PKT
-4,50
PKT
-0,22
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.07.12 | Logitech hold | Vontobel Research | |
| 26.07.12 | Temenos buy | Vontobel Research | |
| 26.07.12 | Temenos neutral | UBS AG | |
| 26.07.12 | Sika hold | Vontobel Research | |
| 26.07.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 25.07.12 | Swatch (I) buy | Deutsche Bank AG | |
| 25.07.12 | Swatch (I) outperform | Credit Suisse Group | |
| 25.07.12 | UBS outperform | Exane-BNP Paribas SA | |
| 25.07.12 | Lonza neutral | Sarasin Research | |
| 25.07.12 | UBS neutral | Nomura | |
| 25.07.12 | Novartis buy | Nomura | |
| 25.07.12 | Swatch (I) buy | UBS AG | |
| 25.07.12 | Novartis kaufen | Sarasin Research | |
| 25.07.12 | Swiss Re buy | Vontobel Research | |
| 25.07.12 | Lonza hold | Vontobel Research | |
| 25.07.12 | Holcim hold | Vontobel Research | |
| 24.07.12 | Swatch (I) buy | Sarasin Research | |
| 24.07.12 | UBS neutral | Sarasin Research | |
| 24.07.12 | UBS hold | Commerzbank Corp. & Markets | |
| 24.07.12 | ams-OSRAM buy | Vontobel Research | |
| 24.07.12 | Julius Bär equal-weight | Morgan Stanley | |
| 24.07.12 | Swiss Re neutral | Nomura | |
| 24.07.12 | Swiss Life buy | Nomura | |
| 24.07.12 | Swatch (I) buy | Vontobel Research | |
| 23.07.12 | Julius Bär buy | Sarasin Research | |
| 23.07.12 | Julius Bär buy | ING | |
| 23.07.12 | Holcim buy | Société Générale Group S.A. (SG) | |
| 23.07.12 | UBS neutral | UBS AG | |
| 23.07.12 | Novartis hold | Vontobel Research | |
| 23.07.12 | Julius Bär hold | Vontobel Research | |
| 23.07.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 20.07.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 20.07.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 20.07.12 | Novartis hold | Vontobel Research | |
| 20.07.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 20.07.12 | SGS SA buy | Vontobel Research | |
| 19.07.12 | Swisscom buy | Banc of America Securities-Merrill Lynch | |
| 19.07.12 | UBS overweight | J.P. Morgan Cazenove | |
| 19.07.12 | UBS hold | Deutsche Bank AG | |
| 19.07.12 | Novartis halten | Independent Research GmbH |